COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Long-Pulsed Dye Laser and Intense Pulsed Light for Skin Rejuvenation.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00375141
Recruitment Status : Terminated (Inclusion, treatments and follow-up are finished)
First Posted : September 12, 2006
Last Update Posted : June 6, 2007
Information provided by:
Bispebjerg Hospital

Brief Summary:
The purpose of the trial is to compare clinical efficacy and occurrence of side effects in the treatment of photodamaged skin with Pulsed Dye Laser and Intense Pulsed Light.

Condition or disease Intervention/treatment Phase
Photodamaged Skin Device: Pulsed dye laser, Intense pulsed light Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single
Actual Study Completion Date : May 2007

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   40 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Mild to moderate bilateral facial photodamage
  • Symmetry in the facial area of wrinkles, skin texture, pigmentary changes and telangiectasia
  • Fitzpatrick's skin type of Type I, II, or III, without significant tan
  • Age > 40 years
  • Able to read and comprehend Danish
  • Informed consent agreement signed by the subject
  • Willingness to follow the treatment schedule and posttreatment follow-up evaluations
  • Willingness to allow photographs of the treated area to be taken for evaluation of efficacy.

Exclusion Criteria:

  • Scarring or infection of the area to be treated
  • Known photosensitivity
  • Presence of a suntan in the area to be treated
  • Subjects taken medication known to induce photosensitivity in the previous three months
  • Known anticoagulation or thromboembolic conditions
  • Subjects taking anticoagulation medication
  • Subjects taking Accutane within the past 6 months
  • Subjects treated with aspirins or anti-inflammatory drugs
  • Subjects who are immunocompromised or have a medical history that is inappropriate for the study per the investigator's clinical judgment.
  • Dermabrasion, chemical peel, laser or IPL treatment, or collagen injection therapy in the facial area in the past 12 months.
  • Previous formation of hypertrophic scars or keloids
  • Subjects who are pregnant or lactating
  • Asymmetry in the facial area of wrinkles, skin texture, pigmentary changes and telangiectasia

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00375141

Layout table for location information
Bispebjerg Hospital
Copenhagen, Denmark, NV
Sponsors and Collaborators
Bispebjerg Hospital
Layout table for investigator information
Principal Investigator: Merete Hædersdal Bispebjerg Hospital
Layout table for additonal information Identifier: NCT00375141    
Other Study ID Numbers: KF-01-316279
First Posted: September 12, 2006    Key Record Dates
Last Update Posted: June 6, 2007
Last Verified: June 2007